QIAGEN N.V. (QGEN) stock
QGENNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$49.56−0.19 (-0.38%)
Close on Nov 18, 2026Market cap $10.75BP/E 25.5Yield 0.50%
Qiagen revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
For fiscal 2025 it was $2.09B, up 5.7% from the year before. Over ten years it grew 5.0% a year on average. The highest annual figure on record is $2.25B in fiscal 2021.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.09B | +5.7% |
| FY2024 | Dec 31, 2024 | $1.98B | +0.7% |
| FY2023 | Dec 31, 2023 | $1.97B | -8.2% |
| FY2022 | Dec 31, 2022 | $2.14B | -4.9% |
| FY2021 | Dec 31, 2021 | $2.25B | +20.4% |
| FY2020 | Dec 31, 2020 | $1.87B | +22.5% |
| FY2019 | Dec 31, 2019 | $1.53B | +1.6% |
| FY2018 | Dec 31, 2018 | $1.50B | +5.9% |
| FY2017 | Dec 31, 2017 | $1.42B | +5.9% |
| FY2016 | Dec 31, 2016 | $1.34B | +4.5% |
| FY2015 | Dec 31, 2015 | $1.28B | -4.7% |
| FY2014 | Dec 31, 2014 | $1.34B | +3.3% |
| FY2013 | Dec 31, 2013 | $1.30B | +3.8% |
| FY2012 | Dec 31, 2012 | $1.25B | +7.2% |
| FY2011 | Dec 31, 2011 | $1.17B | +7.6% |
| FY2010 | Dec 31, 2010 | $1.09B | +7.7% |
| FY2009 | Dec 31, 2009 | $1.01B | +13.1% |
| FY2008 | Dec 31, 2008 | $892.98M | – |
See a number that looks wrong?